Trial record 1 of 3 for:
Debio 0123, monotherapy
A Study to Evaluate Safety and Preliminary Anti-tumor Activity of Debio 0123 as Monotherapy in Adult Participants With Advanced Solid Tumors
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05109975 |
|
Recruitment Status :
Recruiting
First Posted : November 5, 2021
Last Update Posted : March 29, 2024
|
Sponsor:
Debiopharm International SA
Information provided by (Responsible Party):
Debiopharm International SA
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 2026 |
| Estimated Study Completion Date : | June 2027 |